These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32236638)

  • 1. Oral therapies in digestive oncology (Review).
    Prieux-Klotz C; Dermine S; Palmieri LJ; Lavole J; Chaussade S; Brezault C; Coriat R
    Oncol Rep; 2020 Jun; 43(6):1719-1728. PubMed ID: 32236638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeted therapies in digestive oncology].
    Boutayeb S; Bensouda Y; Fadoulkhair Z; Bakkraoui K; Bachouchi M; Errihani H
    Pathol Biol (Paris); 2012 Aug; 60(4):264-8. PubMed ID: 22743093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeted therapies in digestive oncology].
    Amram ML; Benamran DA; Roth AD
    Rev Med Suisse; 2011 May; 7(296):1131-2, 1134-6. PubMed ID: 21721202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDITORIAL: Advances in Pharmacological Treatment of Cancer in Digestive Organs.
    Yee NS
    Curr Clin Pharmacol; 2015; 10(4):254-5. PubMed ID: 26548902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is it possible to predict the response of digestive cancers to chemotherapy?].
    Ballet F
    Gastroenterol Clin Biol; 1983 Apr; 7(4):370-3. PubMed ID: 6873548
    [No Abstract]   [Full Text] [Related]  

  • 6. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digestive neuroendocrine neoplasms: A 2016 overview.
    Merola E; Rinzivillo M; Cicchese N; Capurso G; Panzuto F; Delle Fave G
    Dig Liver Dis; 2016 Aug; 48(8):829-35. PubMed ID: 27212431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialty pharmacy services for patients receiving oral medications for solid tumors.
    Stein J; Mann J
    Am J Health Syst Pharm; 2016 Jun; 73(11):775-96. PubMed ID: 27126828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral chemotherapy in cancers: what about adherence?
    Tanz R; Mahfoud T; Debbagh A; Khmamouch MR; Bazine A; Namad T; Ichou M; Errihani H
    Hematol Oncol Stem Cell Ther; 2012; 5(3):170-1. PubMed ID: 23095796
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing oral chemotherapy: the healthcare practitioner's role.
    Viele CS
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S25-32. PubMed ID: 17468153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in the management of malignant gastrointestinal disease.
    Canfield V; Mortimer JE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):695-714. PubMed ID: 1516963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
    Holle LM; Puri S; Clement JM
    J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe practices and financial considerations in using oral chemotherapeutic agents.
    Bartel SB
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S8-S14. PubMed ID: 17468158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News in digestive oncology].
    Michel P; Di Fiore F
    Bull Cancer; 2008 Jan; 95(1):117-20. PubMed ID: 18230577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of advanced gastrointestinal cancer.
    Geoffroy F; Grem JL
    Curr Opin Oncol; 1994 Jul; 6(4):427-34. PubMed ID: 7803544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer. 35th Congress of the American Society of Clinical Oncology (ASCO), Atlanta, 15-18 May 1999].
    Louvet C
    Rev Med Interne; 1999 Sep; 20(9):749-52. PubMed ID: 10522292
    [No Abstract]   [Full Text] [Related]  

  • 19. [39th congress of the American Society of Clinical Oncology].
    des Guetz G
    J Chir (Paris); 2003 Sep; 140(4):249-50. PubMed ID: 13679777
    [No Abstract]   [Full Text] [Related]  

  • 20. Are patients on oral chemotherapy in your practice setting safe?
    Moody M; Jackowski J
    Clin J Oncol Nurs; 2010 Jun; 14(3):339-46. PubMed ID: 20529795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.